Cargando…
Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability–High Colon Cancer
PURPOSE: Recent clinical trials have reported response rates < 50% among patients treated with programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors for microsatellite instability–high (MSI-H) colorectal cancer (CRC), and factors predicting treatment response have not been fully...
Autores principales: | Hyung, Jaewon, Cho, Eun Jeong, Kim, Jihun, Kim, Jwa Hoon, Kim, Jeong Eun, Hong, Yong Sang, Kim, Tae Won, Sung, Chang Ohk, Kim, Sun Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582482/ https://www.ncbi.nlm.nih.gov/pubmed/35038827 http://dx.doi.org/10.4143/crt.2021.1133 |
Ejemplares similares
-
PD-L1 Expression Is Significantly Associated with Tumor Mutation Burden and Microsatellite Instability Score
por: Cho, Yoon Ah, et al.
Publicado: (2021) -
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair–Deficient/Microsatellite Instability–High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer
por: Kim, Jwa Hoon, et al.
Publicado: (2020) -
Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
por: Kim, Jung Ho, et al.
Publicado: (2016) -
Clinical Utility of a Fully Automated Microsatellite Instability Test with Minimal Hands-on Time
por: Lee, Miseon, et al.
Publicado: (2019) -
PTEN Protein Loss and Loss-of-Function Mutations in Gastric Cancers: The Relationship with Microsatellite Instability, EBV, HER2, and PD-L1 Expression
por: Kim, Binnari, et al.
Publicado: (2020)